Central Nervous System Involvement in Adults with Epidemic Hemolytic Uremic Syndrome

References

1. 1.↵
   1. Griffin PM,
   2. Ostroff SM,
   3. Tauxe RV,
   4. et al

   . Illnesses associated with Escherichia coli O157:H7 infections: a broad clinical spectrum. Ann Intern Med 1988;109:705–12

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Toldo I,
   2. Manara R,
   3. Cogo P,
   4. et al

   . Diffusion-weighted imaging findings in hemolytic uremic syndrome with central nervous system involvement. J Child Neurol 2009;24:247–50

   Abstract/FREE Full Text
3. 3.↵
   1. Sherwood JW,
   2. Wagle WA

   . Hemolytic uremic syndrome: MR findings of CNS complications. AJNR Am J Neuroradiol 1991;12:703–04

   FREE Full Text
4. 4.↵
   1. Jeong YK,
   2. Kim IO,
   3. Kim WS,
   4. et al

   . Hemolytic uremic syndrome: MR findings of CNS complications. Pediatr Radiol 1994;24:585–86

   CrossRefPubMed
5. 5.↵
   1. Ogura H,
   2. Takaoka M,
   3. Kishi M,
   4. et al

   . Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. AJNR Am J Neuroradiol 1998;19:1144–45

   Abstract
6. 6.↵
   1. Hager A,
   2. Staudt M,
   3. Klare B,
   4. et al

   . Hemolytic-uremic syndrome with involvement of basal ganglia and cerebellum. Neuropediatrics 1999;30:210–13

   CrossRefPubMed
7. 7.↵
   1. Yasuhara A,
   2. Araki A,
   3. Ochi A,
   4. et al

   . Magnetic resonance imaging of brain lesions of a patient with hemolytic uremic syndrome following Escherichia coli O157 infection. Pediatr Int 2000;42:302–05

   CrossRefPubMed
8. 8.↵
   1. Signorini E,
   2. Lucchi S,
   3. Mastrangelo M,
   4. et al

   . Central nervous system involvement in a child with hemolytic uremic syndrome. Pediatr Nephrol 2000;14:990–92

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Schmidt S,
   2. Gudinchet F,
   3. Meagher-Villemure K,
   4. et al

   . Brain involvement in haemolytic-uraemic syndrome: MRI features of coagulative necrosis. Neuroradiology 2001;43:581–85

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Bennett B,
    2. Booth T,
    3. Quan A

    . Late onset seizures, hemiparesis and blindness in hemolytic uremic syndrome. Clin Nephrol 2003;59:196–200

    PubMed
11. 11.↵
    1. Vergouwen MD,
    2. Adriani KS,
    3. Roos YB,
    4. et al

    . Proximal cerebral artery stenosis in a patient with hemolytic uremic syndrome. AJNR Am J Neuroradiol 2008;29:e34

    FREE Full Text
12. 12.↵
    1. Koehl B,
    2. Boyer O,
    3. Biebuyck-Gouge N,
    4. et al

    . Neurological involvement in a child with atypical hemolytic uremic syndrome. Pediatr Nephrol 2010;25:2539–42

    CrossRefPubMed
13. 13.↵
    1. Theobald I,
    2. Kuwertz-Broking E,
    3. Schiborr M,
    4. et al

    . Central nervous system involvement in hemolytic uremic syndrome (HUS): a retrospective analysis of cerebral CT and MRI studies. Clin Nephrol 2001;56:S3–8

    PubMed
14. 14.↵
    1. Steinborn M,
    2. Leiz S,
    3. Rudisser K,
    4. et al

    . CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr Radiol 2004;34:805–10

    PubMedWeb of Science
15. 15.↵
    1. Nathanson S,
    2. Kwon T,
    3. Elmaleh M,
    4. et al

    . Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 2010;5:1218–28

    Abstract/FREE Full Text
16. 16.↵
    1. Lapeyraque AL,
    2. Malina M,
    3. Fremeaux-Bacchi V,
    4. et al

    . Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 2011;364:2561–63

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Nakamura H,
    2. Takaba H,
    3. Inoue T,
    4. et al

    . MRI findings of hemolytic uremic syndrome with encephalopathy: widespread symmetrical distribution. J Neuroimaging 2003;13:75–78

    PubMed
18. 18.↵
    1. Taylor MB,
    2. Jackson A,
    3. Weller JM

    . Dynamic susceptibility contrast enhanced MRI in reversible posterior leukoencephalopathy syndrome associated with haemolytic uraemic syndrome. Br J Radiol 2000;73:438–42

    Abstract
19. 19.↵
    1. Frank C,
    2. Werber D,
    3. Cramer JP,
    4. et al

    . Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011;365:1771–80

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Bielaszewska M,
    2. Mellmann A,
    3. Zhang W,
    4. et al

    . Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 2011;11:671–76

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Buchholz U,
    2. Bernard H,
    3. Werber D,
    4. et al

    . German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med 2011;365:1763–70

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Dücker C,
    2. Dautel P,
    3. Wagner K,
    4. et al

    . Clinical symptoms, treatment and outcome of EHEC and EHEC-HUS patients treated as in-patients [in German]. Dtsch Med Wochenschr 2011;136:1770–76

    CrossRefPubMed
23. 23.↵
    1. Gultekin SH,
    2. Rosenfeld MR,
    3. Voltz R,
    4. et al

    . Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123(pt 7):1481–94

    Abstract/FREE Full Text
24. 24.↵
    1. Vincent A,
    2. Bien CG,
    3. Irani SR,
    4. et al

    . Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011;10:759–72

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Flanagan EP,
    2. Caselli RJ

    . Autoimmune encephalopathy. Semin Neurol 2011;31:144–57

    CrossRefPubMed
26. 26.↵
    1. Boccoli J,
    2. Loidl CF,
    3. Lopez-Costa JJ,
    4. et al

    . Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains. Brain Res 2008;1230:320–33

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Fujii J,
    2. Kinoshita Y,
    3. Matsukawa A,
    4. et al

    . Successful steroid pulse therapy for brain lesion caused by Shiga toxin 2 in rabbits. Microb Pathog 2009;46:179–84

    CrossRefPubMed
28. 28.↵
    1. Fujii K,
    2. Matsuo K,
    3. Takatani T,
    4. et al

    . Multiple cavitations in posterior reversible leukoencephalopathy syndrome associated with hemolytic-uremic syndrome. Brain Dev 2012;34:318–21

    CrossRefPubMed
29. 29.↵
    1. Magnus T,
    2. Röther J,
    3. Simova O,
    4. et al

    . The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain 2012;135:1850–59

    Abstract/FREE Full Text
30. 30.↵
    1. Miura S,
    2. Kurita T,
    3. Noda K,
    4. et al

    . Symmetrical brainstem encephalitis caused by herpes simplex virus. J Clin Neurosci 2009;16:589–90

    CrossRefPubMed
31. 31.↵
    1. Kim E,
    2. Na DG,
    3. Kim EY,
    4. et al

    . MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol 2007;28:1652–58

    Abstract/FREE Full Text